Skip to content
FIND A BIOALPS ACTOR

Actor

Calypso Biotech SA

Share this actor

Immunotherapy biotech company that discovers and develops monoclonal antibodies for the treatment of immune pathologies with large unmet medical needs.
The Portfolio consists of two preclinical therapeutic antibodies that intercept key immune checkpoints involved in multiple immune pathologies.
Calypso Biotech targets diseases which incidence has dramatically increased in recent years due to changes in diet and lifestyle, likely through alteration of the microbiome.

Specialties

Primary Therapeutic Areas

1.0 Therapeutic & Diagnostic

1.00 Antibodies & Anti-infectious

1.09 Proteins & Peptides

Business model

1. Entreprise

1.1 Start-Up

Organization Type

Private Company


Visit website

Domains

Endocrine & Metabolic, Immunology & Allergy

Main sector

Biotech

Contact

Chemin des Aulx 14
1228 Plan-les-Ouates / GE